DBV Technologies S.A. (EPA:DBV)
France · Delayed Price · Currency is EUR 2.420
-0.060 (-2.42%)
Last updated: Nov 10, 2025, 5:05 PM CET
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of €409.71 million as of November 10, 2025. Its market cap has increased by 455.29% in one year.
Market Cap
409.71M
Enterprise Value
356.75M
Revenue
4.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.42
Market Cap Chart
Since March 29, 2012, DBV Technologies's market cap has increased from 79.23M to 409.71M, an increase of 417.13%. That is a compound annual growth rate of 12.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 419.01M | 548.55% |
| Dec 31, 2024 | 64.61M | -63.70% |
| Dec 29, 2023 | 177.98M | -39.80% |
| Dec 30, 2022 | 295.62M | 75.76% |
| Dec 31, 2021 | 168.19M | -29.23% |
| Dec 31, 2020 | 237.68M | -74.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.22B |
| Sanofi | 103.96B |
| Sartorius Stedim Biotech | 18.34B |
| bioMérieux | 12.59B |
| Ipsen | 10.44B |
| Eurofins Scientific SE | 10.34B |
| ABIVAX Société Anonyme | 6.68B |
| Virbac | 2.89B |